Evaluation of Mpox Exposures and Outcomes in Workplaces, 6 Jurisdictions, June 1–August 31, 2022
Public Health Reports® · 2024
DOI: 10.1177/00333549241245655 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health Reports®, 2024. Verfasst von Marie A de Perio und 15 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, OH, USA. Hauptthemen laut MEDLINE: Workplace, Contact Tracing. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.
Abstract (Originalsprache)
Objectives
The risk for mpox virus (MPXV) transmission in most workplaces has not been thoroughly assessed in the context of the 2022 global mpox outbreak. Our objectives were to describe mpox case patients who worked while infectious and the subsequent workplace contact tracing efforts, risk assessments, and outcomes.
Methods
The Centers for Disease Control and Prevention requested information from health departments in the United States in September 2022 to identify people with confirmed or probable mpox who worked outside the home while infectious, either before or after diagnosis, from June 1 through August 31, 2022. We collected and summarized data on demographic, clinical, and workplace characteristics of case patients and workplace contact investigations. We stratified data by industry and occupation categories.
Results
In total, 102 case patients were reported by 6 jurisdictions. The most common industries were accommodation and food services (19.8%) and professional business, management, and technical services (17.0%). Contact investigations identified 178 total contacts; 54 cases (52.9%) had no contacts identified. Of 178 contacts, 54 (30.3%) were recommended to receive postexposure prophylaxis (PEP) and 18 (10.1%) received PEP. None of the contacts developed a rash or were tested for orthopox or mpox, and none were reported to have confirmed or probable mpox.
Conclusion
Data from 6 jurisdictions suggest that the risk of MPXV transmission from workers to others in workplace settings in many industries is low. These findings might support future updates to exposure risk classifications and work activity recommendations for patients. These findings also demonstrate the importance of collecting and analyzing occupation and industry data in case reports to better understand risks in workplaces.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, OH, USA.
- National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
- District of Columbia Department of Health, Washington, DC, USA.
- Rhode Island Department of Health, Providence, RI, USA.
- Louisiana Department of Health, Baton Rouge, LA, USA.
- Vermont Department of Health, Burlington, VT, USA.
ORCID-Profile: Marie A de Perio, Jeremy Adams, Diana Valencia
Förderung
- Intramural CDC HHS
Zitieren
APA
de Perio, M. A., Horter, L., Still, W., Meh, I., Persson, N., Berns, A. L., Salinas, A., Murphy, K., Lafferty, A. G., Daltry, D., Mackey, S., Sockwell, D. C., Adams, J., Rivas, J., Somerville, N. J., & Valencia, D. (2024). Evaluation of Mpox Exposures and Outcomes in Workplaces, 6 Jurisdictions, June 1–August 31, 2022. Public Health Reports®. https://doi.org/10.1177/00333549241245655
Vancouver
de Perio MA, Horter L, Still W, Meh I, Persson N, Berns AL, et al. Evaluation of Mpox Exposures and Outcomes in Workplaces, 6 Jurisdictions, June 1–August 31, 2022. Public Health Reports®. 2024. doi:10.1177/00333549241245655
BibTeX
@article{dePerio2024,
author = {de Perio, Marie A and Horter, Libby and Still, William and Meh, Ie and Persson, Nancy and Berns, Abby L and Salinas, Andrea and Murphy, Katherine and Lafferty, Allison G and Daltry, Daniel and Mackey, Skyler and Sockwell, Denise C and Adams, Jeremy and Rivas, Jenniffer and Somerville, Nicholas J and Valencia, Diana},
title = {Evaluation of Mpox Exposures and Outcomes in Workplaces, 6 Jurisdictions, June 1–August 31, 2022},
journal = {Public Health Reports®},
year = {2024},
doi = {10.1177/00333549241245655}
}
EUVIMED